Funding Biopharma Innovation Agenda 

Black

The Financial Times, in partnership with Syneos Health, is bringing together investors, biotechs and big pharma for part two of the Funding Biopharma Innovation series. Join us in person in New York or online as we explore how to create the competitive advantage that enables emerging biotechs to stand out from their peers. Gain insights into the innovative strategies being adopted by biotechs to increase the probability of successful drug development and commercial uptake; and learn how investors in biotechs are achieving positive returns. 

FT Live Syneos Health Funding Biopharma Innovation Event

FT Live and Syneos Health - Funding Biopharma Innovation